Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent Inactivated Split Influenza Vaccine Phase 3 Trial in Young Children
CTR20180580Phase 3Completed
- Sponsor
- Changchun Changsheng Biotechnology
- Start
- Apr 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of quadrivalent inactivated split influenza vaccine in influenza, sponsored by Changchun Changsheng Biotechnology. Started Apr 2018; status: completed.
02
Drugs
quadrivalent inactivated split influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20180580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180580.